Send Inquiry

Request To Call Back

60 Mg Denosumab Injection

Name: 60 Mg Denosumab Injection
Brand: NEETCO BIOPHARMA
Price: 6500 INR
Availability: InStock

Price 6500 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

60 Mg Denosumab Injection Specification

Salt Composition
Denosumab 60 mg

Indication
Treatment of osteoporosis and bone loss conditions

Dosage Form
Injection

Enzyme Types
Monoclonal antibody (not an enzyme)

Feature
Pre-filled syringe for subcutaneous administration

Ingredients
Denosumab, excipients

Application
Medical use for reducing bone loss

Ph Level
Neutral

Physical Color/Texture
Clear to slightly opalescent solution

Fermentation Smell
Odorless

Enzymatic Activity
Non-enzymatic; acts via RANKL inhibition

Storage Instructions
Store in refrigerator at 2C to 8C. Do not freeze. Protect from light.

Shelf Life
24 months

About 60 Mg Denosumab Injection

Experience the finest care with 60 Mg Denosumab Injection - a rarefied option for osteoporosis and bone loss conditions. Advance Purchase allows you to Get It Now, securing an unbeatable price for a pre-filled syringe containing Denosumab 60 mg per 1 ml. This single-use injection, administered subcutaneously every six months, delivers superior results with precision. Approved by regulatory authorities, it features a neutral pH solution in medical grade plastic, stored refrigerated to maintain potency. Prescription only, not recommended for patients with hypocalcemia. Unbeatable in both quality and efficacy, it's the premier choice distributed, exported, and supplied across India.

Outstanding Features and Usage

The 60 Mg Denosumab Injection stands out for its convenient pre-filled syringe designed for direct subcutaneous administration. Ideal for medical professionals, its application helps markedly reduce bone loss in patients diagnosed with osteoporosis or similar conditions. The clear to slightly opalescent solution is odorless, ensuring a comfortable experience during use. Strict storage guidelines require refrigeration between 2C to 8C, guaranteeing product stability and a shelf life of 24 months. Each dose is delivered precisely when needed, every six months or as prescribed.

Domestic Market Reach and Certifications

Within India's robust domestic market, 60 Mg Denosumab Injection enjoys high market value due to stringent certifications and regulatory approvals. Drop-off at designated FOB ports is streamlined for timely delivery, meeting high domestic demand for osteoporosis treatments. Distributors, suppliers, exporters, and traders ensure that the product's market reach covers diverse medical centers, making prescribed care accessible to patients. This reliable supply chain bolsters its reputation amongst healthcare professionals, reinforcing trust in its quality and efficacy.

FAQ's of 60 Mg Denosumab Injection:

Q: How should the 60 Mg Denosumab Injection be administered for optimal results?

A: The 60 Mg Denosumab Injection should be administered subcutaneously by a trained healthcare professional, ideally every six months or as prescribed by your physician. This ensures optimal management of osteoporosis or bone loss conditions.

Q: What are the contraindications for using Denosumab Injection?

A: Denosumab Injection is not recommended for patients with hypocalcemia. Please consult your healthcare provider for a complete assessment of your suitability before starting the treatment.

Q: When should the injection be used during osteoporosis management?

A: This injection is typically used in patients diagnosed with osteoporosis or bone loss, following a doctor's prescription. The dosing schedule is once every six months, or as advised for individual treatment plans.

Q: Where should the Denosumab Injection be stored before administration?

A: The injection must be kept refrigerated at a temperature between 2C to 8C, protected from direct sunlight. Avoid freezing the product to preserve its efficacy throughout the 24-month shelf life.

Q: What benefits does Denosumab Injection offer for bone health?

A: Denosumab Injection delivers direct inhibition of RANKL, helping reduce bone loss and improve bone density in those with osteoporosis. Its rarefied monoclonal antibody composition ensures targeted and effective therapy.

Q: How has Denosumab Injection been approved for use in India?

A: Denosumab Injection is approved by relevant regulatory authorities in India for the treatment of osteoporosis and bone loss conditions. It is distributed, exported, and supplied through certified channels.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number